Stock price when the opinion was issued
Shares are down because the market fears they will do a tie-up deal with Humana, but CI bowed out. This is good given Human's problems. Managers are excellent, making good deals. EPS grew 13% compounded annual growth rate from 2013-2023. Are buying back shares and pay a dividend.
(Analysts’ price target is $397.05)
Do the benefits programs for a lot of small and medium sized businesses and individuals and will benefit from Obama care. It has traded off from fear that businesses would have to now insure all their employees.